HIA
CCXI

Harbor Investment Advisory’s ChemoCentryx, Inc. CCXI Stock Holding History

Harbor Investment Advisory’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,091
Closed -$56K – 1321
2021
Q1 		$56K Buy
1,091
+240
+28% +$14.4K 0.01% 650
2020
Q4 		$53K Buy
851
+331
+64% +$18.9K 0.01% 614
2020
Q3 		$28K Buy
520
+376
+261% +$20.2K 0.01% 662
2020
Q2 		$8K Buy
144
+4
+3% +$218 ﹤0.01% 824
2020
Q1 		$6K Buy
+140
New +$5.95K ﹤0.01% 846

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harbor Investment Advisory's CCXI Position: Q2 2021 in Review

Harbor Investment Advisory sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 1,091 shares — an estimated $56K sold.

Harbor Investment Advisory first reported a position in CCXI in Q1 2020 and held it in 5 quarters. The position peaked at $56K in Q1 2021. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Harbor Investment Advisory reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Harbor Investment Advisory sold 1,091 ChemoCentryx, Inc. shares in Q2 2021, an estimated $56K.
  • Harbor Investment Advisory first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 5 quarters.
  • Harbor Investment Advisory's ChemoCentryx, Inc. position peaked at $56K in Q1 2021.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Harbor Investment Advisory's 13F filing for Q2 2021, filed 27 Jul 2021.